C
Cytek Biosciences, Inc. (CTKB)
NMS – Real vaqt narxi. Valyuta: USD
4.78
+0.04 (0.84%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
4.78
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.78
+0.04 (0.84%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
4.78
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $73.8M umumiy qarzdan $35.2M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $377.9M jami joriy majburiyatlardan $84.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.1) tarmoq o'rtachasidan (1.1) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-40.6x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$849.0K kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 4.48 | 3.40 | 10 | |
| Tezkor likvidlik nisbati | 3.86 | 2.52 | 10 | |
| Qarz/Kapital nisbati | 0.11 | 1.11 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.08 | 1.58 | 9.0 | |
| Foiz to‘lov qoplami | -40.57 | 4.33 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 164M | 193M | 200M | 201M | 207M |
| Yalpi foyda | 102M | 109M | 111M | 104M | 110M |
| Operatsion daromad | -1M | -26M | -23M | -40M | -45M |
| Sof foyda | 3M | -12M | -6M | -67M | -81M |
| EBITDA | 4M | -17M | -13M | -28M | -33M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 1.25 | -1210.33 | 2.0 |
| Keyingi chorak | 2.43 | 99.02 | 6.5 |
| Joriy yil | 3.94 | 44.71 | 7.0 |
| Keyingi yil | 6.59 | 40 | 7.5 |
| O‘rtacha ball | 5.8 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 9.07 | 35.56 | 40 | 82.69 | 9.0 |
| Yil/Yil | 5.57 | -117.76 | -124.99 | 42.21 | 4.3 |
| 3 yil o‘rtacha | 7.35 | -508.8 | 28.54 | 1105.07 | 6.5 |
| 5 yil o‘rtacha | 17.61 | -125.47 | 1.96 | -1029.11 | 3.5 |
| O‘rtacha ball | 5.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |